Answer
Breastfeeding should be discontinued during treatment with Baraclude (entecavir), because excretion into human milk is unknown, animal data show excretion into milk and a risk to infants cannot be excluded.
Sources for this answer
- Baraclude 0.05 mg/ml oral solutionBristol Myers Squibb Pharmaceuticals limited · emc · SmPC §4.6 Fertility, pregnancy and lactation · Version 6Document updated
Sources checked